CBD of Denver Inc. Announces Teleshopping Partnership and Filing of Q3
Ryan Allway
November 21st, 2023
News, Top News, Top Story
Denver, Colorado–(Newsfile Corp. – November 21, 2023) – CBD of Denver, Inc. (OTC Pink: CBDD), today announced that Magic Lappen is set to expand beyond brick and mortar stores to teleshopping as Libra 9 GmbH signed a new partnership with Channel 21 (formerly RTL Shop), the third largest teleshopping channel in Germany.
“We are pleased to announce a partnership between Libra 9 GmbH and Channel 21, one of Germany’s leading teleshopping broadcasters. This partnership marks a significant step for our flagship product, the Magic Lappen, as we introduce it to a broader audience through Channel 21’s extensive network,” stated CBDD CEO Axel Reinke.
Channel 21 is known for its rigorous selection process, emphasizing innovative, high-quality products. The inclusion of the Magic Lappen in their product range is a testament to the exceptional quality and uniqueness of the product.
The Magic Lappen, a revolutionary cleaning cloth that delivers streak-free results with just water, will be available in a convenient 3-piece set through Channel 21. This opportunity to showcase the product on such a reputable platform provides a significant opportunity. Channel 21’s reach extends to approximately 32 million households, providing unparalleled exposure to the target market. This exposure is crucial for demonstrating the unique capabilities and benefits of the Magic Lappen to a wide audience.
The potential for sales growth through this partnership is substantial. Channel 21 has a strong customer base of nearly 6 million shoppers who trust the network for its quality and innovative products. “We are confident that the Magic Lappen will be well-received by this discerning audience, further establishing our brand in the market, and contributing to our sales growth. The premiere of ‘The Magic Lappen’ is scheduled for the end of February, although there is a chance it might debut earlier, possibly in December,” states Mr. Reinke.
CBD of Denver also is announcing the filing of Q3 with OTC markets. The company has sales of $677,893 for Q3 of 2023 vs $26,907 for the same period last year. The sales are approximately $145,000 for Berliner and $532,000 for Luxora. The company is also pleased to announce that the net loss from operations has improved to a loss of $50,850 this quarter vs $219,160 for the same period last year. For the first 9 months of 2023, the loss is $94,284 vs $982,924 for the same period of 2022. The Company’s initiatives have been achieving the desired results. The Company had a board call last week and most of the board and key executives will be meeting in Berlin in early December to continue finalizing Company’s 2024 strategy for both the Berliner and Luxora verticals. One topic of this meeting will be to streamline the reporting process, so the company does not have to apply for another extension again next quarter. This initiative has already been discussed and agreed upon with the Company taking the first steps this Wednesday to put in new support personal, professionals and protocols so the Company is ready to file in a timely matter. The Company will continue to provide updates to the public and our shareholders.
About CBD of Denver, Inc. (BERLINER INNOVATION)
CBD of Denver, Inc. is focused on acquiring profitable assets at attractive valuations to create value for shareholders. The company’s team is dedicated to sourcing high-margin, innovative products that align with its values. The Company is offering a number of innovative consumer products through Libra 9 GmbH, such as the Magic Lappen and the BerlinR13 Anti-Slip solution.
Follow Magic Lappen on Twitter, Instagram, Facebook and TikTok for more information and updates.
Follow The Magic Lappen on Instagram: @themagiclappen
Shop on our website: https://www.the-magic-lappen.com/
Visit the CBDD/ Berliner Innovation: www.berlinerinnovation.de
See our innovative Anti-Slip product: www.berlinr13.de
For questions, please contact us at: investors@libra9.de
About LUXORA LLC
LUXORA LLC is a trailblazing entity in the European cannabis industry, with offices spanning the USA and Europe. Our core expertise revolves around unlocking the potential of the legalized cannabis market, offering infrastructure solutions and consulting tailored to the dynamic needs of this rapidly expanding sector. With a profound understanding of the opportunities and challenges brought forth by legalization, our experienced team is dedicated to pioneering the future of the legal cannabis market in Europe. Our offerings range from consulting and market research to product development and distribution solutions, aimed at simplifying the path to legalization for our esteemed clients.
For inquiries, please contact Investor Relations: investors@luxora-holding.com
For more information, please visit: www.luxora-holding.com
Follow Us: Twitter | Instagram.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Tim has over 22 years of investment experience as a portfolio manager, asset allocator, and capital markets professional across multiple asset classes, geographies, and platforms. Tim has built and operated two hedge funds, a broker dealer, and raised over $1Bn in capital for his combined businesses. Tim remains a recognized voice within the investment community […]
Alan Brochstein’s 420 Investor is the go-to community for investors to learn, explore, and profit from the marijuana companies. The main goal of 420 Investor is to provide real-time, objective information about the top marijuana companies in the market in order to help investors capitalize on cannabis.
BDS Analytics aims to drive the cannabis sector to thrive with well-informed decisions based on factual data. By capturing millions of transactions from dispensary point-of-sale systems we provide actionable insights based on accurate information enabling dispensaries, brands, and growers to sustain their success. Their vision is to be your indispensable source for cannabis industry data […]
Xphyto Therapeutics Corp. was created to bridge the gap between traditional cannabis-based medicine and modern scientific approaches to therapeutic validation.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
